Skip to main content

Advertisement

Table 3 Cardioprotective medication prescription within 1 year of diabetes diagnosis, by sex and cardiovascular disease status

From: Sex-based disparities in cardioprotective medication use in adults with diabetes

< 55 YEARS
  CVD (N = 1,493 ) No CVD (n = 8,953)
  Men Women p-value Men Women p-value
  N = 905 N = 588   N = 4,836 N = 4,117  
Statin 366 (40.4) 180 (30.6) 0.0001 997 (20.6) 596 (14.48) <0.0001
ACEi 431 (47.6) 225 (38.3) 0.0004 1,613 (33.4) 1,071 (26.0) <0.0001
ARB 105 (11.6) 78(13.3) 0.338 410 (8.5) 402 (9.8) 0.035
ACEi or ARB 511 (56.5) 273 (46.4) 0.0001 1,903 (39.4) 1,382 (33.6) <0.0001
At least one of the above 605 (66.9) 340 (57.8) 0.0004 2281 (47.2) 1608 (39.1) <0.0001
55 YEARS +
  CVD (N = 10,019) No CVD (N = 12,829 )
  Men Women p-value Men Women p-value
  N = 5,599 N = 4,420   N = 6,834 N = 5,995  
Statin 1,680 (30.0) 1,142 (25.8) <0.0001 1,325 (19.4) 1,314 (21.9) 0.0004
ACEi 2,653 (47.4) 1,931 (43.7) 0.0002 2,406 (35.2) 2,124 (35.4) 0.8
ARB 600 (10.7) 709 (16.0) <0.0001 760 (11.1) 815 (13.6) <0.0001
ACEi or ARB 3,084 (55.1) 2,458 (55.6) 0.6 2,957 (43.3) 2,759 (46.0) 0.002
At least one of the above 3545 (63.3) 2800 (63.4) 0.9 3415 (49.9) 3263 (54.4) <0.0001
  1. Abbreviations: CVD cardiovascular disease, ACEi angiotensin-converting-enzyme inhibitors, ARB angiotensin receptor blockers.